Fees
Help EIA to grow for your own benefit
5 K EUR
Established companies*, regional authorities, hospitals and research institutions
*Companies with several products on the markets, R & D and/or M & A activities to develop and/or acquire new products.
2.5 K EUR
Growth companies*
*Companies with few or no products on the market but with R & D activities well advanced to develop new solutions.
0.5 K EUR
Startups & spinouts*
*R & D based companies without products on the market and typically before phase 2 clinical trials.
2.5 K EUR
Service providers*
*E.g., CROs, CMOs, IP agencies.
Please note:
- Fees paid in 2023 cover until the end of 2024.
- Fees are subject to changes and are revised annually, first time for the year 2025.
- Information on revision of fees is provided in H1 prior to the year where they take effect.
- Cancellation of a membership shall be informed by e-mail latest in Q 3 to take effect the following year.
- Investors are invited to join free of charge